Comparative Outcomes Between Foot Cast and Short Leg Cast in the Patients With Acute Closed Fracture of Proximal Fifth Metatarsal (Zone II)

September 16, 2018 updated by: Jatupon Kongtharvonskul
This study aims to compare outcomes of short leg cast and foot cast for treatment acute fifth metatarsal fracture (Zone II).

Study Overview

Detailed Description

A randomized controlled trial will conducts between January 2017 and January 2019, participants with acute fifth metatarsal fracture (Zone II) will recruit for this study at the orthopedic outpatient clinic of a police general hospital, Bangkok, Thailand. A total of 100 patients will randomly allocate to receive foot cast or short leg cast. acute closed fracture of proximal fifth metatarsal (zone II) patients.

Study Type

Interventional

Enrollment (Actual)

72

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Select...
      • Bangkok, Select..., Thailand, 10400
        • Jatupon Kongtharvonskul

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years and older (ADULT, OLDER_ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:acute closed fracture of proximal fifth metatarsal (zone II) with following criteria

  1. History of trauma and pain at lateral side of foot
  2. Tenderness at base of 5th metatarsal
  3. Radiographic finding shown fracture line at proximal 5th metatarsal bone

Exclusion Criteria:

  1. more than 1 week
  2. comminuted or multiple fracture
  3. Open fracture
  4. Ligament and tendon injury
  5. Previous injury complication: nonunion, delayed union
  6. Malignancy
  7. refuse to inform consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: foot cast
metatarsal foot cast
ACTIVE_COMPARATOR: short leg cast
full short leg cast

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
VAS
Time Frame: 8 weeks
visual analog score
8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
AOFAS
Time Frame: 8 weeks
foot score
8 weeks
union rate
Time Frame: 8 weeks
radiographic union
8 weeks
complication
Time Frame: 8 weeks
skin ulcer or compartment syndrome
8 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
rescue medication
Time Frame: 8 weeks
paracetamol or NSAIDs
8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 24, 2017

Primary Completion (ACTUAL)

September 1, 2018

Study Completion (ACTUAL)

September 1, 2018

Study Registration Dates

First Submitted

May 25, 2017

First Submitted That Met QC Criteria

May 26, 2017

First Posted (ACTUAL)

May 31, 2017

Study Record Updates

Last Update Posted (ACTUAL)

September 18, 2018

Last Update Submitted That Met QC Criteria

September 16, 2018

Last Verified

September 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Closed Fracture of Proximal Fifth Metatarsal (Zone II)

Clinical Trials on short foot cast

3
Subscribe